TPST Tempest Therapeutics Inc

Price (delayed)

$0.922

Market cap

$14.73M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$4.28

Enterprise value

$21.51M

Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 5

OvaScience, Inc., is a life science company developing products to improve the treatment of female infertility based on recent scientific discoveries about the existence of egg precursor cells. The Company ...

Highlights
The EPS has soared by 71% YoY and by 29% from the previous quarter
Tempest Therapeutics's debt has decreased by 13% YoY and by 3.7% from the previous quarter
The equity has plunged by 111% YoY
The quick ratio has dropped by 91% year-on-year and by 67% since the previous quarter

Key stats

What are the main financial stats of TPST

TPST stock price

How has the Tempest Therapeutics stock price performed over time
Intraday
-7.8%
1 week
-23.8%
1 month
-11.35%
1 year
-89.64%
YTD
-67.87%
QTD
-16.94%

Financial performance

How have Tempest Therapeutics's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$40.64M
Net income
-$40.47M
Gross margin
N/A
Net margin
N/A
The company's operating income rose by 6% YoY and by 6% QoQ
The net income has grown by 6% YoY and by 6% from the previous quarter

Price vs fundamentals

How does TPST's price correlate with its fundamentals

Growth

What is Tempest Therapeutics's growth rate over time

Valuation

What is Tempest Therapeutics stock price valuation
P/E
N/A
P/B
N/A
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has soared by 71% YoY and by 29% from the previous quarter
The equity has plunged by 111% YoY

Efficiency

How efficient is Tempest Therapeutics business performance
The company's return on assets has shrunk by 128% YoY and by 20% QoQ
The ROE has plunged by 74% from the previous quarter
TPST's return on invested capital is up by 11% year-on-year and by 6% since the previous quarter

Dividends

What is TPST's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for TPST.

Financial health

How did Tempest Therapeutics financials performed over time
The company's total assets is 10% lower than its total liabilities
The quick ratio has dropped by 91% year-on-year and by 67% since the previous quarter
The current ratio has dropped by 82% year-on-year and by 49% since the previous quarter
The debt to equity has dropped by 173% since the previous quarter
The equity has plunged by 111% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.